PE20180396A1 - Una composicion farmaceutica antiviral de uso topico - Google Patents

Una composicion farmaceutica antiviral de uso topico

Info

Publication number
PE20180396A1
PE20180396A1 PE2017002343A PE2017002343A PE20180396A1 PE 20180396 A1 PE20180396 A1 PE 20180396A1 PE 2017002343 A PE2017002343 A PE 2017002343A PE 2017002343 A PE2017002343 A PE 2017002343A PE 20180396 A1 PE20180396 A1 PE 20180396A1
Authority
PE
Peru
Prior art keywords
pharmaceutical composition
topical use
antiviral pharmaceutical
antiviral
quaternary ammonium
Prior art date
Application number
PE2017002343A
Other languages
English (en)
Inventor
Luis Alberto Arganaras
Original Assignee
Quim Luar Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Quim Luar Srl filed Critical Quim Luar Srl
Publication of PE20180396A1 publication Critical patent/PE20180396A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/78—Polymers containing oxygen of acrylic acid or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4425—Pyridinium derivatives, e.g. pralidoxime, pyridostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Abstract

Una composicion farmaceutica antiviral de uso topico contra aquellos virus con envoltura lipidica, que comprende como principios activos un copolimero cationico conteniendo grupos aminos terciarios, y un tensioactivo cationico conteniendo grupos amonios cuaternarios
PE2017002343A 2015-05-15 2016-05-13 Una composicion farmaceutica antiviral de uso topico PE20180396A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ARP150101519A AR100459A1 (es) 2015-05-15 2015-05-15 Una composición farmacéutica antiviral de uso tópico

Publications (1)

Publication Number Publication Date
PE20180396A1 true PE20180396A1 (es) 2018-02-28

Family

ID=57319498

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2017002343A PE20180396A1 (es) 2015-05-15 2016-05-13 Una composicion farmaceutica antiviral de uso topico

Country Status (11)

Country Link
US (1) US10478452B2 (es)
EP (1) EP3295934B1 (es)
AR (1) AR100459A1 (es)
BR (1) BR112017024399B1 (es)
CL (1) CL2017002796A1 (es)
CO (1) CO2017011297A2 (es)
ES (1) ES2915824T3 (es)
IL (1) IL255635A (es)
MX (1) MX2017014162A (es)
PE (1) PE20180396A1 (es)
WO (1) WO2016185069A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022219944A1 (ja) * 2021-04-16 2022-10-20 株式会社日本触媒 抗コロナウイルス剤

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3743727A (en) * 1970-11-16 1973-07-03 Crown Zellerbach Corp Enhancing tissue penetration of certain antimicrobial agents with dimethyl sulfoxide
US4902720A (en) * 1983-01-10 1990-02-20 Baldone Joseph A Treatment of virus infections with quaternary ammonium compounds
US5160737A (en) * 1988-05-03 1992-11-03 Perio Products Ltd. Liquid polymer composition, and method of use
BRPI0014271B1 (pt) * 1999-09-24 2021-06-22 Janssen Pharmaceutica N.V. Partícula consistindo em uma dispersão de sólidos, uso da dita partícula, dispersão de sólidos, forma de dosagem farmacêutica, bem como processos de preparação de dita partícula, dispersão e forma de dosagem
US6855341B2 (en) 2002-11-04 2005-02-15 Jeffrey B. Smith Anti-viral compositions and methods of making and using the anti-viral compositions
US7968122B2 (en) * 2003-12-10 2011-06-28 Adventrx Pharmaceuticals, Inc. Anti-viral pharmaceutical compositions
ITMI20051417A1 (it) * 2005-07-22 2007-01-23 Mipharm S P A Formulazione topica in forma di gel contenente come ingredienti attivi ciclovit e lidocaina
US8119115B2 (en) * 2006-02-09 2012-02-21 Gojo Industries, Inc. Antiviral method
US7883487B2 (en) * 2008-06-16 2011-02-08 Shantha Totada R Transdermal local anesthetic patch with injection port
US20140328895A1 (en) * 2011-03-29 2014-11-06 Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. Film-forming composition for a ph-dependant sustained release of the active agent

Also Published As

Publication number Publication date
MX2017014162A (es) 2018-06-20
WO2016185069A1 (es) 2016-11-24
US20180250327A1 (en) 2018-09-06
CO2017011297A2 (es) 2018-01-31
BR112017024399A2 (pt) 2019-02-05
IL255635A (en) 2018-01-31
EP3295934A1 (en) 2018-03-21
EP3295934B1 (en) 2022-03-02
ES2915824T3 (es) 2022-06-27
EP3295934A4 (en) 2019-01-02
BR112017024399B1 (pt) 2022-06-07
CL2017002796A1 (es) 2018-07-13
AR100459A1 (es) 2016-10-05
US10478452B2 (en) 2019-11-19

Similar Documents

Publication Publication Date Title
BR112015014482A2 (pt) vacinas para vírus influenza e seus usos
BR112021006270A2 (pt) lipídeos de amina ionizáveis
BR112018011122A2 (pt) antígenos, vetores, composições, e métodos de utilização para o vírus da imunodeficiência humana dos mesmos
CL2016002269A1 (es) Moduladores alostéricos del núcleo proteico de la hepatitis b.
CL2015003615A1 (es) Nucleósidos sustituidos, nucleótidos y análogos de los mismos.
CO2017001994A2 (es) Compuestos activos hacia bromodominios
CL2016000381A1 (es) Compuestos antivirales
BR112018008090A2 (pt) vacina de vírus do herpes simplex.
BR112019001737A2 (pt) expressão de pten-long com vírus oncolíticos
BR112015027321A8 (pt) Compostos e composições para modular a expressão de apolipoproteína(a) e seus usos
CU20160187A7 (es) (2r,5s,13ar)-7,9-dioxo-10-((2,4,6-trifluorobencil)carbamoil)-2,3,4,5,7,9,13, 13a-octahidro-2,5-metanopirido[1',2':4,5]pirazino[2,1-b][1,3]oxazepin-8-olato de sodio
BR112017000528A2 (pt) moduladores dos receptores toll-like para o tratamento do hiv
CL2015001916A1 (es) Derivados de pirimidona y su uso en el tratamiento, mejora o prevención de una enfermedad viral.
BR112016026205A2 (pt) Moduladores de entrançamento de gene smn2, seu uso e seu processo de preparação, e composições farmacêuticas
BR112015009189A2 (pt) conjunto de potência para um autoinjetor e autoinjetor que contém o mesmo
CL2014000956A1 (es) Compuestos derivados de (4-fenilimidazol-2-il)etilamina, como moduladores de canal de sodio; composicion farmaceutica que los comprende; y su uso en el tratamiento del dolor.
BR112014033080A2 (pt) inibidores do vírus da hepatite c
TR201910293T4 (tr) Nazal influenza aşısı bileşimi.
CL2016001973A1 (es) Derivados de nucleosido sustituidos con 4' -difluorometilo como inhibidores de la replicación de arn de la influenza.
CR20160502A (es) Anticuerpos de hemaglutinina contra el virus de la influenza b y métodos de uso
CL2017003107A1 (es) Derivados de 2-(pirazolopiridin-3-il)pirimidina como inhibidores de jak
BR112018002983A2 (pt) composição compreendendo uma lactama e um álcool
MX2017009812A (es) Composiciones y metodos para inhibir infeccion viral.
BR112016022046A2 (pt) Derivados de 8-(piperazin-1-il)-1,2,3,4-tetrahidro-isoquinolina
BR112016005417A8 (pt) "compostos derivados de desoxinojirimicina, composição farmacêutica e seus usos"